SCHEMBL7850737

SCHEMBL7850737

O=C(O)c1ncccc1C(=O)C1CCCCC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.63
ALDH1A1 P00352 4/20 0.63
GAA P10253 1/20 0.63
MAPT P10636 2/20 0.59
CYP3A4 P08684 1/20 0.59
ALOX15 P16050 1/20 0.59
TSHR P16473 1/20 0.59
BLM P54132 1/20 0.59
AGER Q15109 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
ASPH Q12797 1/20 0.47
KDM8 Q8N371 1/20 0.47
SRD5A2 P31213 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 1/20 0.41
NAPRT Q6XQN6 2/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5211190 0.79 SLC18A3 (0.56) KDM4EALDH1A1GAACYP3A4CYP1A2
SCHEMBL8183855 0.79 SMN1; SMN2 (0.54) KDM4EALDH1A1GAAMAPTTSHR
SCHEMBL3055032 0.79 NAPRT (0.54) KDM4EALDH1A1GAACYP3A4CYP1A2
SCHEMBL5047657 0.79 SLC18A3 (0.56) KDM4EALDH1A1GAACYP3A4CYP1A2
SCHEMBL31432000 0.78 ALDH1A1 (1.00) KDM4EALDH1A1GAAMAPTCYP3A4
SCHEMBL30885089 0.77 PARP1 (0.55) ALDH1A1GAATSHRLMNAKMT2A
SCHEMBL3027381 0.76 ALDH1A1 (0.54) KDM4EALDH1A1GAAALOX15NPSR1
SCHEMBL20711523 0.76 KDM4E (0.43) KDM4EALDH1A1GAATSHRLMNA
Quinolinic Acid SCHEMBL69230 0.75 KDM4E (1.00) KDM4EALDH1A1GAAMAPTCYP3A4
Quinolinic Acid SCHEMBL343618 0.75 KDM4E (1.00) KDM4EALDH1A1GAAMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0652218-B1 Heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2001-07-11 EP disclosed
US-5585385-A USEFUL IN TREATING DISORDERS OF MICTURITION; ADMINISTERING TO INHIBIT PLASMA EXTRAVASATION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-17 US disclosed
EP-0652218-A1 Heterocyclic compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1995-05-10 EP disclosed